Skip to main content

Advertisement

Log in

Decreased serum vitamin D levels are associated with diabetic peripheral neuropathy in a rural area of Turkey

  • Original Article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

Abstract

Data examining the association between vitamin D and diabetic peripheral neuropathy are limited. This study investigated the serum levels of vitamin D, vitamin D-binding protein (VDBP), and vitamin D receptor (VDR) in diabetics in the Yozgat region of Turkey, and assessed their relationships with diabetic peripheral neuropathy. 69 diabetic patients and 49 age- and sex-matched control subjects were enrolled in this clinical prospective study. All the diabetics underwent conventional sensory and motor nerve conduction studies, and diabetic peripheral neuropathy was confirmed or ruled out according to the electromyography findings and Douleur Neuropathique 4 questions. Serum vitamin D, VDBP and VDR levels were measured using commercial enzyme-linked immunosorbent assay kits. The serum vitamin D levels (p = 0.001) were significantly lower, while the VDR levels (p = 0.003) were higher, in diabetics than in controls. The serum VDBP levels were similar in both groups (p > 0.05). The serum vitamin D levels were significantly lower in diabetics with diabetic peripheral neuropathy than in those without (p = 0.032), whereas the serum VDBP and VDR levels were similar in these two groups (p > 0.05). The lower serum vitamin D levels in diabetics, especially in those with peripheral neuropathy, may suggest a neurotrophic effect of vitamin D.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Holick MF (2007) Vitamin D deficiency. New Engl J Med 357(3):266–281. doi:10.1056/NEJMra070553

    Article  CAS  PubMed  Google Scholar 

  2. Makariou S, Liberopoulos EN, Elisaf M, Challa A (2011) Novel roles of vitamin D in disease: what is new in 2011? Eur J Intern Med 22(4):355–362. doi:10.1016/j.ejim.2011.04.012

    Article  CAS  PubMed  Google Scholar 

  3. Pierrot-Deseilligny C (2009) Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol 256(9):1468–1479. doi:10.1007/s00415-009-5139-x

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, Hupperts R (2009) Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 4(8):e6635. doi:10.1371/journal.pone.0006635

    Article  PubMed Central  PubMed  Google Scholar 

  5. Zipitis CS, Akobeng AK (2008) Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 93(6):512–517. doi:10.1136/adc.2007.128579

    Article  CAS  PubMed  Google Scholar 

  6. The NS, Crandell JL, Lawrence JM, King IB, Dabelea D, Marcovina SM, D’Agostino RB Jr, Norris JM, Pihoker C, Mayer-Davis EJ (2013) Vitamin D in youth with type 1 diabetes: prevalence of insufficiency and association with insulin resistance in the SEARCH Nutrition Ancillary Study. Diabet Med 30(11):1324–1332. doi:10.1111/dme.12297

    Article  CAS  PubMed  Google Scholar 

  7. Tohidi M, Bozorgmanesh M, Mohebi R, Khalili D, Saadat N, Khorrami N, Azizi F, Hadaegh F (2013) Non-linear association between 25-hydroxyvitamin D and the incidence of type 2 diabetes: a community-based nested case-control study. Diabetic Med 30(8):934–938. doi:10.1111/Dme.12180

    Article  CAS  PubMed  Google Scholar 

  8. Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92(6):2017–2029. doi:10.1210/jc.2007-0298

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Argoff CE, Cole BE, Fishbain DA, Irving GA (2006) Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc 81(4 Suppl):S3–S11

    Article  PubMed  Google Scholar 

  10. Girach A, Manner D, Porta M (2006) Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract 60(11):1471–1483. doi:10.1111/j.1742-1241.2006.01175.x

    Article  CAS  PubMed  Google Scholar 

  11. Bell DS (2012) Reversal of the symptoms of diabetic neuropathy through correction of vitamin D deficiency in a type 1 diabetic patient. Case Rep Endocrinol 2012:165056. doi:10.1155/2012/165056

    PubMed Central  PubMed  Google Scholar 

  12. Soderstrom LH, Johnson SP, Diaz VA, Mainous AG (2012) Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001–2004 NHANES. Diabet Med 29(1):50–55. doi:10.1111/j.1464-5491.2011.03379.x

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Shehab D, Al-Jarallah K, Mojiminiyi OA, Al Mohamedy H, Abdella NA (2012) Does vitamin D deficiency play a role in peripheral neuropathy in type 2 diabetes? Diabet Med 29(1):43–49. doi:10.1111/j.1464-5491.2011.03510.x

    Article  CAS  PubMed  Google Scholar 

  14. Skalli S, Muller M, Pradines S, Halimi S, Wion-Barbot N (2012) Vitamin D deficiency and peripheral diabetic neuropathy. Eur J Intern Med 23(2):e67–e68. doi:10.1016/j.ejim.2011.11.008

    Article  CAS  PubMed  Google Scholar 

  15. Lee P, Chen R (2008) Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain. Arch Intern Med 168(7):771–772. doi:10.1001/archinte.168.7.771

    Article  PubMed  Google Scholar 

  16. Rhee SY, Hwang YC, Chung HY, Woo JT (2012) Vitamin D and diabetes in Koreans: analyses based on the Fourth Korea National Health and Nutrition Examination Survey (KNHANES), 2008–2009. Diabet Med 29(8):1003–1010. doi:10.1111/j.1464-5491.2012.03575.x

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. American Diabetes A (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32(Suppl 1):S62–S67. doi:10.2337/dc09-S062

    Article  Google Scholar 

  18. Singleton JR, Smith AG, Bromberg MB (2001) Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24(8):1448–1453

    Article  CAS  PubMed  Google Scholar 

  19. Prakash S, Mehta NC, Dabhi AS, Lakhani O, Khilari M, Shah ND (2010) The prevalence of headache may be related with the latitude: a possible role of vitamin D insufficiency? J Headache Pain 11(4):301–307. doi:10.1007/s10194-010-0223-2

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lanteri-Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E (2005) Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114(1–2):29–36. doi:10.1016/j.pain.2004.12.010

    Article  PubMed  Google Scholar 

  21. Chandy A, Pawar B, John M, Isaac R (2008) Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications. Saudi J Kidney Dis Transpl 19(6):924–928

    PubMed  Google Scholar 

  22. Petrone AB, Weir NL, Steffen BT, Tsai MY, Gaziano JM, Djousse L (2013) Plasma vitamin D-binding protein and risk of heart failure in male physicians. Am J Cardiol 112(6):827–830. doi:10.1016/j.amjcard.2013.05.014

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Boucher BJ (2011) Vitamin D insufficiency and diabetes risks. Curr Drug Targets 12(1):61–87

    Article  CAS  PubMed  Google Scholar 

  24. George PS, Pearson ER, Witham MD (2012) Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 29(8):e142–e150. doi:10.1111/j.1464-5491.2012.03672.x

    Article  CAS  PubMed  Google Scholar 

  25. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G, Atherosclerosis Risk in Communities S (2003) Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52(7):1799–1805

    Article  CAS  PubMed  Google Scholar 

  26. Hewison M (2010) Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 39(2):365–379. doi:10.1016/j.ecl.2010.02.010 table of contents

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Danescu LG, Levy S, Levy J (2009) Vitamin D and diabetes mellitus. Endocrine 35(1):11–17. doi:10.1007/s12020-008-9115-5

    Article  CAS  PubMed  Google Scholar 

  28. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R (2003) The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 57(4):258–261

    CAS  PubMed  Google Scholar 

  29. Palomer X, Gonzalez-Clemente JM, Blanco-Vaca F, Mauricio D (2008) Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 10(3):185–197. doi:10.1111/j.1463-1326.2007.00710.x

    Article  CAS  PubMed  Google Scholar 

  30. Riaz S, Malcangio M, Miller M, Tomlinson DR (1999) A vitamin D (3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia 42(11):1308–1313. doi:10.1007/s001250051443

    Article  CAS  PubMed  Google Scholar 

  31. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002) New clues about vitamin D functions in the nervous system. Trends Endocrin Met 13(3):100–105. doi:10.1016/S1043-2760(01)00547-1

    Article  CAS  Google Scholar 

  32. Plotnikoff GA, Quigley JM (2003) Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78(12):1463–1470. doi:10.4065/78.12.1463

    Article  PubMed  Google Scholar 

  33. Valensi P, Le Devehat C, Richard JL, Farez C, Khodabandehlou T, Rosenbloom RA, LeFante C (2005) A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J Diabetes Complicat 19(5):247–253. doi:10.1016/j.jdiacomp.2005.05.011

    Article  PubMed  Google Scholar 

  34. Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C (2002) A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol 9(2):131–136. doi:10.1038/nsb754

    Article  CAS  PubMed  Google Scholar 

  35. White P, Cooke N (2000) The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 11(8):320–327

    Article  CAS  PubMed  Google Scholar 

  36. Nyomba BL, Bouillon R, Lissens W, Vanbaelen H, Demoor P (1985) 1,25-Dihydroxyvitamin-D and vitamin D-binding Protein are both decreased in streptozotocin-diabetic rats. Endocrinology 116(6):2483–2488

    Article  CAS  PubMed  Google Scholar 

  37. Chiu KC, Chu A, Go VLW, Saad MF (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79(5):820–825

    CAS  PubMed  Google Scholar 

  38. Chuang JC, Cha JY, Garmey JC, Mirmira RG, Repa JJ (2008) Research resource: nuclear hormone receptor expression in the endocrine pancreas. Mol Endocrinol 22(10):2353–2363. doi:10.1210/me.2007-0568

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Choi M, Ozeki J, Hashizume M, Kato S, Ishihara H, Makishima M (2012) Vitamin D receptor activation induces peptide YY transcription in pancreatic islets. Endocrinology 153(11):5188–5199. doi:10.1210/en.2012-1396

    Article  CAS  PubMed  Google Scholar 

  40. Bland R, Markovic D, Hills CE, Hughes SV, Chan SL, Squires PE, Hewison M (2004) Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89–90(1–5):121–125. doi:10.1016/j.jsbmb.2004.03.115

    Article  PubMed  Google Scholar 

  41. Ordonez-Moran P, Munoz A (2009) Nuclear receptors: genomic and non-genomic effects converge. Cell Cycle 8(11):1675–1680

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Asuman Celikbilek.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Celikbilek, A., Gocmen, A.Y., Tanik, N. et al. Decreased serum vitamin D levels are associated with diabetic peripheral neuropathy in a rural area of Turkey. Acta Neurol Belg 115, 47–52 (2015). https://doi.org/10.1007/s13760-014-0304-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-014-0304-0

Keywords

Navigation